Atrium Therapeutics, Inc. (RNA) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading RNA…

Atrium Therapeutics, Inc. (RNA) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

Atrium Therapeutics, Inc.

RNA · CIK 2093101

4 · Sep 22, 2026 · Chief Strategy Officer Hoyos Rocio Martin reported 8,320 shares

4

Chief Strategy Officer Hoyos Rocio Martin reported 8,320 shares

Filed: Sep 22, 2026
Period: Sep 18, 2026
Accession: 0001193125-26-397936
Filer: Atrium Therapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov